Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

93.75 -0.89 (-0.94%)
Official Closing Price Updated: 7:00 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Merck Announces Third-Quarter 2022 Dividend
From Merck & Co., Inc.
Via Business Wire
FDA Lifts Partial Hold On Alpine Immune's Davoceticept Combo Trial In Advanced Cancer
 
Via Benzinga
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of Recurrence
From Merck & Co., Inc.
Via Business Wire
CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting
 
Via Benzinga
Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer
 
Via Benzinga
7 Blue-Chip Stocks With Dividends to Buy Before June
Blue-chip stocks with dividends pay investors to wait for a rally by the stock market and tend to be quite resilient. 
Via InvestorPlace
S&P 500 1Q22 Earnings Recap: Growth Holding Up
With about 95% of the S&P 500 constituents having reported 1Q22 earnings, we look at aggregate performance and EPS estimates of the eleven S&P500 sectors during the past earnings season and look ahead... 
Via Talk Markets
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
 
Via Benzinga
7 Quality Dividend Stocks to Buy on the Dip
While the current market environment is full of uncertainty, these dividend stocks to buy offer a hedge against the rampant inflation rates. 
Via InvestorPlace
7 Retirement Stocks to Buy for Any Market Conditions
Though investors’ nerves are shaken due to the volatility, these proven ideas should withstand the pressure. 
Via InvestorPlace
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection
From Merck & Co., Inc.
Via Business Wire
Oncocyte Reports That Its First-Of-Its-Kind DetermaCNI Blood Test That Tracks Cancer Treatment Progress Could Hit Market By 2023
Image by Nguyễn Hiệp on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
As Keytruda's patent protection looms, will Merck be able to stanch the sales losses? 
Via Investor's Business Daily
7 Dividend Stocks to Boost Your Retirement Savings
This is a very good time to look for quality foundational stocks that not only have growth potential but are solid dividend stocks, too. 
Via InvestorPlace
Merck & Co Whale Trades For May 18
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Jazz Pharmaceuticals Stock Sees Rising Price Performance With Jump To 81 RS Rating
Jazz Pharmaceuticals sees its Relative Strength Rating move into the 80-plus level. 
Via Investor's Business Daily
CNBC's Final Trades: Low Volatility ETF, Kinder Morgan And This Pharma Major
On CNBC’s “Halftime Report Final Trades,” Liz Young of BNY Mellon Investment Management chose Invesco S&P 500 Low Volatility ETF (NYSE: SPLV), saying that “we have to fig 
Via Benzinga
4 Stocks Moved By Traders On 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
7 Retirement Stocks for Steady Long-Term Income Growth
Investors looking for retirement stocks should look for companies with high growth and steady income and shun risky, unproven stocks. 
Via InvestorPlace
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. 
Via Talk Markets
Stocks Are Undervalued
The bear growled this past week as the S&P 500 Index skirted the (-20%) threshold. But Friday the markets bounced back, much to investors’ relief. The Index is still in a correction, although that may... 
Via Talk Markets
7 Profitable Places to Hide Your Money During a Bear Market
With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification. 
Via InvestorPlace
CNBC's Final Trades: Charles Schwab And These 3 Medical Stocks
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said Charles Schwab Corporation (NYSE: SCHW) is trading at 14 times next year’s earnings. 
Via Benzinga
15 Stocks Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
Analyzing Merck & Co's Short Interest
Merck & Co's (NYSE:MRK) short percent of float has risen 14.93% since its last report. The company recently reported that it has 19.28 million shares sold short, which is 0.77... 
Via Benzinga
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)
From Merck & Co., Inc.
Via Business Wire
Dow Giants Chevron, Merck Lead Five Stocks Showing Strength In A Bad Market
Dow giants Chevron and Merck are among stocks to watch. 
Via Investor's Business Daily
7 Defensive Dividend Healthcare Stocks to Buy Now
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. 
Via InvestorPlace
This Company Is Reportedly Solving Bedroom Performance Issues Behind Closed Doors
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.